Oncology Central

Management of hepatocellular carcinoma: time to be resilient

European Association for the Study of the Liver Hepatocellular Carcinoma Summit

13–14 February 2014, Geneva, Switzerland

Following on from the publication of clinical practice guidelines [1], the European Association for the Study of the Liver (EASL) organized a 2-day conference focused on the management of hepatocellular carcinoma (HCC). Over 700 delegates convened in Geneva in mid-February 2014. This report selects a few important points that were discussed at the meeting.

In comparison to other tumors, where the use of biomarkers has become routine in guiding clinical practice, none of them are used in HCC and the field is lagging behind. Several groups have published molecular classifications of HCCs, which are informative, and help us better understand the biology of

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.